Treatment · May 19, 2026
New Blood Pressure Drug Targets Root Cause of Hypertension for First Time
FDA approves a new blood pressure medication providing patients with an additional hypertension management option....
Treatment · May 18, 2026
New Hypertension Drug Targets Hormone to Lower Stubbornly High Blood Pressure
FDA approval of the first aldosterone synthase inhibitor provides a new treatment option for hypertension patients....
Treatment · May 18, 2026
FDA Approves First-in-Class Pill for Tough to Treat High Blood Pressure
AstraZeneca's new blood pressure pill opens a new drug class for hypertension treatment....
Breakthrough · December 2, 2025
FDA Grants Priority Review to New Hypertension Drug for Treatment-Resistant Cases
Baxdrostat receives FDA priority review as a promising new option for patients struggling to control hypertension....